Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Managed Care & Specialty Pharmacy|July 27, 2016
Estimating the Economic Impact of Adding Panobinostat to a U.S. Formulary for Relapsed and/or Refractory Multiple Myeloma: A Budget Impact and Cost-Benefit ModelLisa Bloudek, Anuja Roy, Jonathan K Kish, et al.Clinical Therapeutics|March 24, 2009
A framework for planning and critiquing medication compliance and persistence research using prospective study designsFemida H Gwadry-Sridhar, Elizabeth Manias, Ying Zhang, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 2, 2008
Medication compliance and persistence: terminology and definitionsJoyce A Cramer, Anuja Roy, Anita Burrell, et al.Annals of Hematology|February 18, 2020
Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review studyRégis Peffault de Latour, Lynn Huynh, Jasmina I Ivanova, et al.American Health & Drug Benefits|July 10, 2015
Estimating the Costs of Therapy in Patients with Relapsed and/or Refractory Multiple Myeloma: A Model FrameworkAnuja Roy, Jonathan K Kish, Lisa Bloudek, et al.The American Journal of Cardiology|January 13, 2022
Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service PopulationJamieson M Bourque, Alexander Schepart, Rahul Bhambri, et al.Acta Haematologica|March 31, 2021
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi PanelNichola Cooper, Quentin A Hill, John Grainger, et al.Journal of Patient-Reported Outcomes|May 15, 2018
Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experimentA Simon Pickard, Lynn Huynh, Jasmina I Ivanova, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 13, 2023
Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United StatesRahul Bhambri, A Carmine Colavecchia, Marianna Bruno, et al.Expert Review of Hematology|June 14, 2016
Real-world treatment patterns and associated progression-free survival in relapsed/refractory multiple myeloma among US community oncology practicesSundar Jagannath, Anuja Roy, Jonathan Kish, et al.Pageof 3